• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后住院患者的颅内出血:来自单一中心的大型队列分析

Intracranial Hemorrhage in Hospitalized Patients Following Percutaneous Coronary Intervention: A Large Cohort Analysis from a Single Center.

作者信息

Yang Cheng, Sui Yong-Gang, Wang Bin-Cheng, Xu Yan-Lu, Wu Na-Qiong, Wu Yong-Jian, Li Jian-Jun, Qian Jie

机构信息

Department of Cardiology, Fu Wai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China.

出版信息

Diagnostics (Basel). 2023 Jul 20;13(14):2422. doi: 10.3390/diagnostics13142422.

DOI:10.3390/diagnostics13142422
PMID:37510165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10378240/
Abstract

BACKGROUND

There are several reports on the prevalence and characteristics of intracranial hemorrhage (ICH) following percutaneous coronary intervention (PCI), which is a rare but severe complication with high mortality. However, the clinical landscapes of computed tomography (CT)-confirmed, symptomatic ICH in hospitalized patients are not fully characterized.

METHODS

Among 121,066 patients receiving PCI treatment in the Fu Wai Hospital between 2013 and 2022, there were 18 CT-defined, symptomatic patients with ICH occurring during post-PCI hospitalization. Symptomatic ICH was defined as clinical suspicion of hemorrhage and/or new focal neurological signs. We analyzed ICH timing, clinical and imaging features, and subsequent outcomes.

RESULTS

Overall, in this retrospective analysis, the incidence of CT-defined, symptomatic ICH was 0.015% (18/121,066). More than half of the cases (55.6%) occurred within the first 12 h following PCI. The most common initial manifestation of ICH patients was disturbance of consciousness. Thirteen patients (72.2%) had a hematoma volume ≥ 30 cm. Additionally, the ICH was observed in the cerebral lobe (66.7%), cerebellum (22.2%), and the basal ganglia and thalamus (11.1%). The 90-day mortality of ICH patients undergoing PCI was very high (72.2%). Consciousness disturbance ( = 0.036), intracerebral hemorrhage volume > 30 mm ( = 0.001), and intracerebral hemorrhage originating from the infratentorial origin ( = 0.044) were significantly higher in patients who died.

CONCLUSIONS

Symptomatic ICH events occur with a rate of around 0.015%, with significantly higher short-term mortality risk in our cohort receiving PCI, which has not yet been demonstrated in other cohorts.

摘要

背景

关于经皮冠状动脉介入治疗(PCI)后颅内出血(ICH)的患病率和特征已有多篇报道,这是一种罕见但严重的并发症,死亡率很高。然而,住院患者中经计算机断层扫描(CT)确诊的有症状ICH的临床情况尚未完全明确。

方法

在2013年至2022年期间于阜外医院接受PCI治疗的121,066例患者中,有18例在PCI术后住院期间发生了CT定义的有症状ICH。有症状ICH被定义为临床怀疑出血和/或新出现的局灶性神经体征。我们分析了ICH的发生时间、临床和影像学特征以及后续结局。

结果

总体而言,在这项回顾性分析中,CT定义的有症状ICH的发生率为0.015%(18/12,1066)。超过一半的病例(55.6%)发生在PCI后的前12小时内。ICH患者最常见的初始表现是意识障碍。13例患者(72.2%)血肿体积≥30 cm³。此外,ICH见于脑叶(66.7%)、小脑(22.2%)以及基底节和丘脑(11.1%)。接受PCI治疗后的ICH患者90天死亡率非常高(72.2%)。死亡患者的意识障碍(P = 0.036)、脑出血体积>30 mm³(P = 0.001)以及幕下起源的脑出血(P = 0.044)明显更高。

结论

有症状ICH事件的发生率约为0.015%,在我们接受PCI治疗的队列中短期死亡风险显著更高,这在其他队列中尚未得到证实。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1704/10378240/d76222edb25f/diagnostics-13-02422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1704/10378240/d4557de003ac/diagnostics-13-02422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1704/10378240/d76222edb25f/diagnostics-13-02422-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1704/10378240/d4557de003ac/diagnostics-13-02422-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1704/10378240/d76222edb25f/diagnostics-13-02422-g002.jpg

相似文献

1
Intracranial Hemorrhage in Hospitalized Patients Following Percutaneous Coronary Intervention: A Large Cohort Analysis from a Single Center.经皮冠状动脉介入治疗后住院患者的颅内出血:来自单一中心的大型队列分析
Diagnostics (Basel). 2023 Jul 20;13(14):2422. doi: 10.3390/diagnostics13142422.
2
Intracranial Bleeding After Percutaneous Coronary Intervention: Time-Dependent Incidence, Predictors, and Impact on Mortality.经皮冠状动脉介入治疗后的颅内出血:时间依赖性发生率、预测因素及其对死亡率的影响。
J Am Heart Assoc. 2021 Aug 3;10(15):e019637. doi: 10.1161/JAHA.120.019637. Epub 2021 Jul 29.
3
Symptomatic intracerebral hemorrhage after non-emergency percutaneous coronary intervention: Incidence, risk factors, and association with cardiovascular outcomes.非急诊经皮冠状动脉介入治疗后有症状性脑出血:发病率、危险因素及与心血管结局的关联
Front Cardiovasc Med. 2022 Sep 16;9:936498. doi: 10.3389/fcvm.2022.936498. eCollection 2022.
4
Intracranial Hemorrhage in Hospitalized Patients: An Infrequently Studied Condition with High Mortality.住院患者颅内出血:一种研究较少但死亡率较高的疾病。
Neurocrit Care. 2020 Dec;33(3):725-731. doi: 10.1007/s12028-020-00946-y.
5
Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.溶栓相关颅内出血:对来自GUSTO-1试验的244例病例的影像学分析及临床相关性。链激酶和组织型纤溶酶原激活剂在冠状动脉闭塞中的全球应用。
Stroke. 1998 Mar;29(3):563-9. doi: 10.1161/01.str.29.3.563.
6
Evaluation of Volumetric Change of Intracerebral Hemorrhage in Patients Treated with Thrombolysis for Intraventricular Hemorrhage.评价溶栓治疗脑室出血患者的脑内血肿体积变化。
Neurocrit Care. 2021 Apr;34(2):529-536. doi: 10.1007/s12028-020-01054-7. Epub 2020 Jul 31.
7
Surgical evacuation of neonatal intracranial hemorrhage due to vitamin K deficiency bleeding.因维生素K缺乏性出血导致的新生儿颅内出血的手术清除
J Neurosurg Pediatr. 2011 Mar;7(3):295-9. doi: 10.3171/2010.12.PEDS10473.
8
Warfarin-associated intracerebral hemorrhage: volume, anticoagulation intensity and location.华法林相关性脑出血:出血量、抗凝强度与部位。
J Neurol Sci. 2013 Sep 15;332(1-2):75-9. doi: 10.1016/j.jns.2013.06.020. Epub 2013 Jul 30.
9
Intracranial hemorrhage in full-term newborns: a hospital-based cohort study.足月新生儿颅内出血:基于医院的队列研究。
Neuroradiology. 2010 Jun;52(6):567-76. doi: 10.1007/s00234-010-0698-1.
10
Predictors of 30-day mortality in patients with spontaneous primary intracerebral hemorrhage.自发性原发性脑出血患者30天死亡率的预测因素。
Surg Neurol Int. 2016 Aug 1;7(Suppl 18):S510-7. doi: 10.4103/2152-7806.187493. eCollection 2016.

引用本文的文献

1
Clinical characteristics and outcomes of hospitalized patients with intracranial hemorrhage after percutaneous coronary intervention.经皮冠状动脉介入治疗后颅内出血住院患者的临床特征及预后
Front Cardiovasc Med. 2025 Mar 11;12:1424598. doi: 10.3389/fcvm.2025.1424598. eCollection 2025.
2
Clinical and subclinical acute brain injury caused by invasive cardiovascular procedures.侵入性心血管操作引起的临床和亚临床急性脑损伤。
Nat Rev Cardiol. 2025 Apr;22(4):273-303. doi: 10.1038/s41569-024-01076-0. Epub 2024 Oct 11.

本文引用的文献

1
2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association.2022年自发性脑出血患者管理指南:美国心脏协会/美国中风协会指南
Stroke. 2022 Jul;53(7):e282-e361. doi: 10.1161/STR.0000000000000407. Epub 2022 May 17.
2
Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association.《心脏病与卒中统计-2022 更新:美国心脏协会报告》。
Circulation. 2022 Feb 22;145(8):e153-e639. doi: 10.1161/CIR.0000000000001052. Epub 2022 Jan 26.
3
Intracranial Bleeding After Percutaneous Coronary Intervention: Time-Dependent Incidence, Predictors, and Impact on Mortality.
经皮冠状动脉介入治疗后的颅内出血:时间依赖性发生率、预测因素及其对死亡率的影响。
J Am Heart Assoc. 2021 Aug 3;10(15):e019637. doi: 10.1161/JAHA.120.019637. Epub 2021 Jul 29.
4
Outcomes in Antiplatelet-Associated Intracerebral Hemorrhage in the TICH-2 Randomized Controlled Trial.抗血小板相关脑出血患者的 TICH-2 随机对照试验结果。
J Am Heart Assoc. 2021 Feb;10(5):e019130. doi: 10.1161/JAHA.120.019130. Epub 2021 Feb 15.
5
Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association.《心脏病与卒中统计-2020 更新:来自美国心脏协会的报告》。
Circulation. 2020 Mar 3;141(9):e139-e596. doi: 10.1161/CIR.0000000000000757. Epub 2020 Jan 29.
6
Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease.双重途径抑制在心血管疾病中的二级和三级抗栓预防。
Nat Rev Cardiol. 2020 Apr;17(4):242-257. doi: 10.1038/s41569-019-0314-y. Epub 2020 Jan 17.
7
Incidence, predictors and prognostic impact of intracranial bleeding within the first year after an acute coronary syndrome in patients treated with percutaneous coronary intervention.经皮冠状动脉介入治疗的急性冠状动脉综合征患者在发病后一年内颅内出血的发生率、预测因素和预后影响。
Eur Heart J Acute Cardiovasc Care. 2020 Oct;9(7):764-770. doi: 10.1177/2048872619827471. Epub 2019 May 1.
8
Intracerebral haemorrhage: current approaches to acute management.脑出血:急性处理的当前方法。
Lancet. 2018 Oct 6;392(10154):1257-1268. doi: 10.1016/S0140-6736(18)31878-6.
9
Trade-off of myocardial infarction vs. bleeding types on mortality after acute coronary syndrome: lessons from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) randomized trial.急性冠状动脉综合征后心肌梗死与出血类型对死亡率的权衡:来自急性冠状动脉综合征临床事件减少凝血酶受体拮抗剂(TRACER)随机试验的经验教训。
Eur Heart J. 2017 Mar 14;38(11):804-810. doi: 10.1093/eurheartj/ehw525.
10
Determinants and Outcomes of Stroke Following Percutaneous Coronary Intervention by Indication.经皮冠状动脉介入治疗后按适应症划分的卒中的决定因素及结局
Stroke. 2016 Jun;47(6):1500-7. doi: 10.1161/STROKEAHA.116.012700. Epub 2016 May 10.